Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6021 USD | -3.21% | -3.21% | -39.79% |
2023 | EV Biologics, Inc. Closes A $500,000 Interest-Free Loan | CI |
2023 | Ev Biologics Completes Production of Cutting-Edge Msc Exosome-Based Therapeutic | CI |
Sales 2016 | 42.64M 3.55B | Sales 2017 | 9.51M 792M | Capitalization | 6.09M 508M |
---|---|---|---|---|---|
Net income 2016 | -53M -4.42B | Net income 2017 | -7M -583M | EV / Sales 2016 | 0.69 x |
Net Debt 2016 | 9M 750M | Net Debt 2017 | 10.03M 836M | EV / Sales 2017 | 1.7 x |
P/E ratio 2016 |
-0.38
x | P/E ratio 2017 |
-0.82
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 23.58% |
1 day | -3.21% | ||
1 week | -3.21% | ||
Current month | -3.21% | ||
3 months | -14.24% | ||
6 months | -56.68% | ||
Current year | -39.79% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel McKinney
CEO | Chief Executive Officer | 62 | 29/18/29 |
Jason Sanders
BRD | Director/Board Member | 46 | 31/20/31 |
William Bossung
BRD | Director/Board Member | - | 07/23/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel McKinney
CEO | Chief Executive Officer | 62 | 29/18/29 |
William Bossung
BRD | Director/Board Member | - | 03/18/03 |
Jason Sanders
BRD | Director/Board Member | 46 | 31/20/31 |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 0.6021 | -3.21% | 3 500 |
Delayed Quote OTC Markets, May 03, 2024 at 07:29 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
-39.79% | 6.36M | |
+18.45% | 47.78B | |
+4.32% | 15.72B | |
-5.15% | 15.14B | |
-10.14% | 10.73B | |
+28.73% | 8.85B | |
+105.28% | 7.85B | |
-3.59% | 7.71B | |
-7.03% | 7.5B | |
+24.84% | 6.76B |
- Stock Market
- Equities
- YECO Stock